Cargando…

Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study

BACKGROUND: Adherence issues in polycystic ovary syndrome (PCOS) patients have not been examined thoroughly. Patients report prolonged periods of treatment and side effects of the drug as the most common reason for withdrawal from treatment. To improve the effective management of PCOS patients, it i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazarganipour, Fatemeh, Taghavi, Seyed Abdolvahab, Allan, Helen, Hosseini, Nazafarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Clinical Center for Infertility 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894471/
https://www.ncbi.nlm.nih.gov/pubmed/29662963
_version_ 1783313502508679168
author Bazarganipour, Fatemeh
Taghavi, Seyed Abdolvahab
Allan, Helen
Hosseini, Nazafarin
author_facet Bazarganipour, Fatemeh
Taghavi, Seyed Abdolvahab
Allan, Helen
Hosseini, Nazafarin
author_sort Bazarganipour, Fatemeh
collection PubMed
description BACKGROUND: Adherence issues in polycystic ovary syndrome (PCOS) patients have not been examined thoroughly. Patients report prolonged periods of treatment and side effects of the drug as the most common reason for withdrawal from treatment. To improve the effective management of PCOS patients, it is fundamental to understand facilitating and inhibiting factors to treatment adherence. OBJECTIVE: To explore facilitating/inhibiting factors related to treatment adherence among PCOS patients. MATERIALS AND METHODS: This was a qualitative study with a purposive sample of women with confirmed diagnosis of PCOS. The data were collected via 20 in-depth semi-structured interviews with women aged between 21-34 yr. A qualitative content analysis was used to analyze the data. RESULTS: Five themes were identified which described different types of facilitating/ inhibiting factors to treatment adherence. Inhibiting factors included financial issues, patient-related, disease-related, and health care provider-related factors; while social factors were found to be both facilitating and inhibiting. CONCLUSION: The findings suggest that successful adherence to PCOS treatment is highly dependent on patients recognizing and adapting to financial, social, and health care related inhibiting factors. It is also crucial for clinicians and policy makers to recognize these key inhibiting factors in order to improve treatment outcomes.
format Online
Article
Text
id pubmed-5894471
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Research and Clinical Center for Infertility
record_format MEDLINE/PubMed
spelling pubmed-58944712018-04-16 Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study Bazarganipour, Fatemeh Taghavi, Seyed Abdolvahab Allan, Helen Hosseini, Nazafarin Int J Reprod Biomed Original Article BACKGROUND: Adherence issues in polycystic ovary syndrome (PCOS) patients have not been examined thoroughly. Patients report prolonged periods of treatment and side effects of the drug as the most common reason for withdrawal from treatment. To improve the effective management of PCOS patients, it is fundamental to understand facilitating and inhibiting factors to treatment adherence. OBJECTIVE: To explore facilitating/inhibiting factors related to treatment adherence among PCOS patients. MATERIALS AND METHODS: This was a qualitative study with a purposive sample of women with confirmed diagnosis of PCOS. The data were collected via 20 in-depth semi-structured interviews with women aged between 21-34 yr. A qualitative content analysis was used to analyze the data. RESULTS: Five themes were identified which described different types of facilitating/ inhibiting factors to treatment adherence. Inhibiting factors included financial issues, patient-related, disease-related, and health care provider-related factors; while social factors were found to be both facilitating and inhibiting. CONCLUSION: The findings suggest that successful adherence to PCOS treatment is highly dependent on patients recognizing and adapting to financial, social, and health care related inhibiting factors. It is also crucial for clinicians and policy makers to recognize these key inhibiting factors in order to improve treatment outcomes. Research and Clinical Center for Infertility 2017-09 /pmc/articles/PMC5894471/ /pubmed/29662963 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bazarganipour, Fatemeh
Taghavi, Seyed Abdolvahab
Allan, Helen
Hosseini, Nazafarin
Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study
title Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study
title_full Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study
title_fullStr Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study
title_full_unstemmed Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study
title_short Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study
title_sort facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: a qualitative study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894471/
https://www.ncbi.nlm.nih.gov/pubmed/29662963
work_keys_str_mv AT bazarganipourfatemeh facilitatingandinhibitingfactorsrelatedtotreatmentadherenceinwomenwithpolycysticovarysyndromeaqualitativestudy
AT taghaviseyedabdolvahab facilitatingandinhibitingfactorsrelatedtotreatmentadherenceinwomenwithpolycysticovarysyndromeaqualitativestudy
AT allanhelen facilitatingandinhibitingfactorsrelatedtotreatmentadherenceinwomenwithpolycysticovarysyndromeaqualitativestudy
AT hosseininazafarin facilitatingandinhibitingfactorsrelatedtotreatmentadherenceinwomenwithpolycysticovarysyndromeaqualitativestudy